Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Exclusive worldwide rights offered for peptide-cleaving endopeptidase

Nov. 28, 1996

Potential drug screening invention available for licensing

Nov. 27, 1996

Tularik receives patent coverage relating to drug discovery efforts

Nov. 26, 1996

Cytel/Abbott collaboration reaches milestone

Nov. 22, 1996

Theratechnologies and AEterna sign technology licensing agreement

Nov. 22, 1996

IVAX and Glaxo Wellcome to expand Easi-Breathe agreement

Nov. 21, 1996

LTB4-PPARalpha as a new target for drug design

Nov. 20, 1996

U.S. patents and suits related to transgenic mice producing human antibodies

Nov. 15, 1996

Patent covers Advanced Magnetics' targeted drug delivery system

Nov. 15, 1996

Alanex and Aurora join forces to identify new lead compounds

Nov. 15, 1996

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...